| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.24 | 0.0004 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |